DRDO Grants Permission To Mankind Pharma To Manufacture & Market Anti-Covid Drug 2-DG
On Thursday, The Pharmaceuticals firm Mankind Pharma informed that it has received a licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), an…